Ambry Genetics

09/09/2025

The Gene Scene is here to empower your practice! Discover how insights into APC can guide actionable health recommendations and support personalized care in your clinic for APC-related familial adenomatous polyposis (AD) and colorectal cancer disposition. Read more from Amanda Jacquart, MS, CGC:
https://hubs.ly/Q03HvHTx0

09/03/2025

Meet Matthew Do, Ambry AI/ML Summer Intern.

09/03/2025

Meet Ambry summer intern Brandon Huang, Product Management Intern.

09/03/2025

Meet Sandy Nguyenphuoc, Ambry Business Systems Analyst Intern.

09/02/2025

Join us for a webinar Thursday, September 4, at 11 am PT.
https://hubs.ly/Q03Grw4S0

09/02/2025

Heading to Take the Lead in Breast Cancer Care Summit in New Orleans September 26-27? Meet with our experts to explore how smarter screening and prevention start with risk insights.

09/02/2025

The Gene Scene is here to empower your practice! Discover how insights into RPS20 can guide actionable health recommendations and support personalized care in your clinic for colorectal cancer disposition. Read more from Catherine Mayo, MS, CGC:
https://hubs.ly/Q03Grr8g0

09/01/2025

This Labor Day, we're celebrating the hard work and dedication of our incredible team at Ambry Genetics. We recognize the labors of love that drive our journey. Today and every day we recognize their passion for patients and enthusiasm for developing the next stage of healthcare! Here's to the synergy of science and hard work! We wish you a restful Labor Day!

08/28/2025

Just published in JCO Precision Oncology: Our latest study of nearly 1 million individuals reveals that loss-of-function variants in RPS20 carry a colorectal cancer risk comparable to MLH1. Read more here: https://hubs.ly/Q03F_Xml0.

PURPOSERPS20 is a proposed colorectal cancer (CRC) predisposition gene, with only four families with putative loss-of-function (pLoF) variants published. The prevalence, phenotypic spectrum, and clinical management recommendations for RPS20 heterozygotes ...

08/27/2025

How has a groundbreaking Nature study—along with the Ambry Classifi® Program—impacted 4,200 patients…and counting? Discover how proactively reclassifying BRCA2 variants moved them from uncertainty to clarity.
https://hubs.ly/Q03FPfxG0

08/27/2025

Everyone’s talking about the perfect match this week. In our world, the perfect match is DNA and RNA working together to reveal actionable insights.

08/26/2025

We’re thrilled to launch our brand-new series, Making Waves, dedicated to spotlighting the extraordinary work of healthcare providers who are creating ripple effects of impact in their communities.

For our very first story, we’re honored to feature Arravinth (Avi) Anantharajah, MS, LCGC, genetic counselor at the Penn Medicine Basser Center for BRCA, whose compassion and creativity helped fulfill a mother’s final wish: completing genetic testing for her daughters in her last days.

This remarkable act of care is a powerful reminder that the waves healthcare providers make extend far beyond a single patient—they touch families, futures, and generations to come.

🌊 Dive into Avi’s story and the debut of Making Waves: https://hubs.ly/Q03Fs8Tn0